Cargando…
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
Background Coronavirus disease 2019 (COVID-19) vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. The problem is that despite such spectacular results, vaccination alone will not be able to control the COVID-19 pandemic because of the rapid e...
Autores principales: | Bakacs, Tibor, Sandig, Volker, Kovesdi, Imre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511982/ https://www.ncbi.nlm.nih.gov/pubmed/36176842 http://dx.doi.org/10.7759/cureus.28467 |
Ejemplares similares
-
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
por: Bakacs, Tibor, et al.
Publicado: (2023) -
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
por: Bakacs, Tibor, et al.
Publicado: (2022) -
Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections
por: Bakacs, Tibor, et al.
Publicado: (2022) -
Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia
por: Kleef, Ralf, et al.
Publicado: (2021) -
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
por: Bakacs, Tibor, et al.
Publicado: (2018)